Small Molecule Inhibitors of RnpA Alter Cellular mRNA Turnover, Exhibit Antimicrobial Activity, and Attenuate Pathogenesis


Methicillin-resistant Staphylococcus aureus is estimated to cause more U.S. deaths annually than HIV/AIDS. The emergence of hypervirulent and multidrug-resistant strains has further amplified public health concern and accentuated the need for new classes of antibiotics. RNA degradation is a required cellular process that could be exploited for novel antimicrobial drug development. However, such discovery efforts have been hindered because components of the Gram-positive RNA turnover machinery are incompletely defined. In the current study we found that the essential S. aureus protein, RnpA, catalyzes rRNA and mRNA digestion in vitro. Exploiting this activity, high through-put and secondary screening assays identified a small molecule inhibitor of RnpA-mediated in vitro RNA degradation. This agent was shown to limit cellular mRNA degradation and exhibited antimicrobial activity against predominant methicillin-resistant S. aureus (MRSA) lineages circulating throughout the U.S., vancomycin intermediate susceptible S. aureus (VISA), vancomycin resistant S. aureus (VRSA) and other Gram-positive bacterial pathogens with high RnpA amino acid conservation. We also found that this RnpA-inhibitor ameliorates disease in a systemic mouse infection model and has antimicrobial activity against biofilm-associated S. aureus. Taken together, these findings indicate that RnpA, either alone, as a component of the RNase P holoenzyme, and/or as a member of a more elaborate complex, may play a role in S. aureus RNA degradation and provide proof of principle for RNA catabolism-based antimicrobial therapy.


Vyšlo v časopise: Small Molecule Inhibitors of RnpA Alter Cellular mRNA Turnover, Exhibit Antimicrobial Activity, and Attenuate Pathogenesis. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001287
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001287

Souhrn

Methicillin-resistant Staphylococcus aureus is estimated to cause more U.S. deaths annually than HIV/AIDS. The emergence of hypervirulent and multidrug-resistant strains has further amplified public health concern and accentuated the need for new classes of antibiotics. RNA degradation is a required cellular process that could be exploited for novel antimicrobial drug development. However, such discovery efforts have been hindered because components of the Gram-positive RNA turnover machinery are incompletely defined. In the current study we found that the essential S. aureus protein, RnpA, catalyzes rRNA and mRNA digestion in vitro. Exploiting this activity, high through-put and secondary screening assays identified a small molecule inhibitor of RnpA-mediated in vitro RNA degradation. This agent was shown to limit cellular mRNA degradation and exhibited antimicrobial activity against predominant methicillin-resistant S. aureus (MRSA) lineages circulating throughout the U.S., vancomycin intermediate susceptible S. aureus (VISA), vancomycin resistant S. aureus (VRSA) and other Gram-positive bacterial pathogens with high RnpA amino acid conservation. We also found that this RnpA-inhibitor ameliorates disease in a systemic mouse infection model and has antimicrobial activity against biofilm-associated S. aureus. Taken together, these findings indicate that RnpA, either alone, as a component of the RNase P holoenzyme, and/or as a member of a more elaborate complex, may play a role in S. aureus RNA degradation and provide proof of principle for RNA catabolism-based antimicrobial therapy.


Zdroje

1. ShorrAF

TabakYP

KillianAD

GuptaV

LiuLZ

2006 Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med 34 2588 2595

2. BancroftEA

2007 Antimicrobial resistance: it's not just for hospitals. Jama 298 1803 1804

3. KlevensRM

MorrisonMA

NadleJ

PetitS

GershmanK

2007 Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Jama 298 1763 1771

4. AppelbaumPC

2007 Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 30 398 408

5. ZetolaN

FrancisJS

NuermbergerEL

BishaiWR

2005 Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5 275 286

6. CarpousisAJ

2007 The RNA degradosome of Escherichia coli: an mRNA-degrading machine assembled on RNase E. Annu Rev Microbiol 61 71 87

7. MackieGA

1998 Ribonuclease E is a 5′-end-dependent endonuclease. Nature 395 720 723

8. VanzoNF

LiYS

PyB

BlumE

HigginsCF

1998 Ribonuclease E organizes the protein interactions in the Escherichia coli RNA degradosome. Genes Dev 12 2770 2781

9. CondonC

2003 RNA processing and degradation in Bacillus subtilis. Microbiol Mol Biol Rev 67 157 174, table of contents

10. EvenS

PellegriniO

ZigL

LabasV

VinhJ

2005 Ribonucleases J1 and J2: two novel endoribonucleases in B. subtilis with functional homology to E. coli RNase E. Nucleic Acids Res 33 2141 2152. Print 2005

11. MathyN

BenardL

PellegriniO

DaouR

WenT

2007 5′-to-3′ exoribonuclease activity in bacteria: role of RNase J1 in rRNA maturation and 5′ stability of mRNA. Cell 129 681 692

12. CommichauFM

RotheFM

HerzbergC

WagnerE

HellwigD

2009 Novel activities of glycolytic enzymes in Bacillus subtilis: interactions with essential proteins involved in mRNA processing. Mol Cell Proteomics 8 1350 1360

13. MaderU

ZigL

KretschmerJ

HomuthG

PutzerH

2008 mRNA processing by RNases J1 and J2 affects Bacillus subtilis gene expression on a global scale. Mol Microbiol 70 183 196

14. YaoS

SharpJS

BechhoferDH

2009 Bacillus subtilis RNase J1 endonuclease and 5′ exonuclease activities in the turnover of DeltaermC mRNA. Rna 15 2331 2339

15. ShahbabianK

JamalliA

ZigL

PutzerH

2009 RNase Y, a novel endoribonuclease, initiates riboswitch turnover in Bacillus subtilis. Embo J 28 3523 3533

16. Lehnik-HabrinkM

PfortnerH

RempetersL

PietackN

HerzbergC

2010 The RNA degradosome in Bacillus subtilis: identification of CshA as the major RNA helicase in the multiprotein complex. Mol Microbiol 21 21

17. KobayashiK

EhrlichSD

AlbertiniA

AmatiG

AndersenKK

2003 Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A 100 4678 4683

18. NovickRP

2003 Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48 1429 1449

19. AndersonKL

RobertsC

DiszT

VonsteinV

HwangK

2006 Characterization of the Staphylococcus aureus heat-shock, cold-shock, stringent, and SOS responses and their effects on log-phase mRNA turnover. J Bacteriol 188 6739 6756

20. RobertsC

AndersonKL

MurphyE

ProjanSJ

MountsW

2006 Characterizing the Effect of the Staphylococcus aureus Virulence Factor Regulator, SarA, on Log-Phase mRNA Half-Lives. J Bacteriol 188 2593 2603

21. TakayamaK

KjellebergS

2000 The role of RNA stability during bacterial stress responses and starvation. Environ Microbiol 2 355 365

22. AndersonKL

DunmanPM

2009 Messenger RNA Turnover Processes in Escherichia coli, Bacillus subtilis, and Emerging Studies in Staphylococcus aureus. Int J Microbiol 2009 525491

23. FrankDN

PaceNR

1998 Ribonuclease P: unity and diversity in a tRNA processing ribozyme. Annu Rev Biochem 67 153 180

24. KazantsevAV

PaceNR

2006 Bacterial RNase P: a new view of an ancient enzyme. Nat Rev Microbiol 4 729 740

25. WalkerSC

EngelkeDR

2006 Ribonuclease P: the evolution of an ancient RNA enzyme. Crit Rev Biochem Mol Biol 41 77 102

26. HartmannRK

GossringerM

SpathB

FischerS

MarchfelderA

2009 The making of tRNAs and more - RNase P and tRNase Z. Prog Mol Biol Transl Sci 85 319 368

27. GossringerM

Kretschmer-Kazemi FarR

HartmannRK

2006 Analysis of RNase P protein (rnpA) expression in Bacillus subtilis utilizing strains with suppressible rnpA expression. J Bacteriol 188 6816 6823

28. SchedlP

PrimakoffP

1973 Mutants of Escherichia coli thermosensitive for the synthesis of transfer RNA. Proc Natl Acad Sci U S A 70 2091 2095

29. WaughDS

PaceNR

1990 Complementation of an RNase P RNA (rnpB) gene deletion in Escherichia coli by homologous genes from distantly related eubacteria. J Bacteriol 172 6316 6322

30. LundbladEW

XiaoG

KoJH

AltmanS

2008 Rapid selection of accessible and cleavable sites in RNA by Escherichia coli RNase P and random external guide sequences. Proc Natl Acad Sci U S A 105 2354 2357

31. LiuF

AltmanS

1994 Differential evolution of substrates for an RNA enzyme in the presence and absence of its protein cofactor. Cell 77 1093 1100

32. MarvinMC

EngelkeDR

2009 Broadening the mission of an RNA enzyme. J Cell Biochem 108 1244 1251

33. LetunicI

CopleyRR

PilsB

PinkertS

SchultzJ

2006 SMART 5: domains in the context of genomes and networks. Nucleic Acids Res 34 D257 260

34. SchultzJ

MilpetzF

BorkP

PontingCP

1998 SMART, a simple modular architecture research tool: identification of signaling domains. Proc Natl Acad Sci U S A 95 5857 5864

35. SpitzfadenC

NicholsonN

JonesJJ

GuthS

LehrR

2000 The structure of ribonuclease P protein from Staphylococcus aureus reveals a unique binding site for single-stranded RNA. J Mol Biol 295 105 115

36. ChaudhuriRR

AllenAG

OwenPJ

ShalomG

StoneK

2009 Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH). BMC Genomics 10 291

37. JiY

ZhangB

VanSF

Horn

WarrenP

2001 Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293 2266 2269

38. CharpentierE

AntonAI

BarryP

AlfonsoB

FangY

2004 Novel cassette-based shuttle vector system for gram-positive bacteria. Appl Environ Microbiol 70 6076 6085

39. McDougalLK

StewardCD

KillgoreGE

ChaitramJM

McAllisterSK

2003 Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41 5113 5120

40. WeissEC

SpencerHJ

DailySJ

WeissBD

SmeltzerMS

2009 Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation. Antimicrob Agents Chemother 53 2475 2482

41. BeenkenKE

DunmanPM

McAleeseF

MacapagalD

MurphyE

2004 Global Gene Expression in Staphylococcus aureus Biofilms. J Bacteriol 186 4665 4684

42. HuntzingerE

BoissetS

SaveanuC

BenitoY

GeissmannT

2005 Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression. EMBO J 24 824 835. Epub 2005 Jan 2027

43. KoleR

BaerMF

StarkBC

AltmanS

1980 E. coli RNAase P has a required RNA component. Cell 19 881 887

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa